CrisprBits develops PathCrisp for detection of AMR

The CRISPR-based platform combats antibiotic resistance in hospital-acquired infections by delivering results within two hours, enabling faster and targeted treatment for patients Bengaluru-based biotechnology startup CrisprBits has developed PathCrisp, a platform for CRISPR-based molecular diagnostics for early detection of antibiotic resistance in hospital-acquired infections. Carba